The Latest Breaking News from Quest Diagnostics

As Quest Diagnostics gears up to unveil its second-quarter earnings results, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Plus, an AI-generated version of the same article

Fitbit and Pixel Watch owners can participate in a metabolic health study, which involves providing digital health data and a blood sample.

Amphetamine use is on the rise as well.

ST. LOUIS — While marijuana legalization proponents celebrated victory in their fight for recreational cannabis, Missouri business owners were phoning their lawyers.

Masimo Corporation (NASDAQ: MASI) delivered adjusted earnings per share (ETF:EPS) of $1.35 in the second quarter of 2022, up 43.6% year over year. The figure surpassed the Zacks Consensus Estimate by 13.5%.

The Biden administration has started shipping testing kits for monkeypox to commercial laboratories, in a bid to speed diagnostic tests for suspected infections for the virus that has already infected at least 142 people in the U.S. The Centers for Disease Control and Prevention is sending tests to commercial labs,…

The Meaning Behind Value Stocks

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Quest Diagnostics Inc (NYSE:DGX) posted a better-than-expected Q1 FY22 adjusted EPS of $3.22, down 14.4% Y/Y, beating the consensus of $2.97. Sales came in at $2.61 billion, a decline of 4% Y/Y, slightly lower than the Wall Street estimate of $2.63 billion. COVID-19 testing revenues fell 27.6% to $599 million, while Base…

  Quest Diagnostics (NYSE:DGX) reported its Q1 earnings results on Thursday, April 21, 2022 at 06:45 AM. Here's what investors need to know about the announcement.